Report of Foreign Issuer (6-k)

---

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

 

For the month of February 2017

 

Commission File Number: 001-36073

 

                    ENZYMOTEC LTD.                     
(Translation of registrant's name into English)

 

Sagi 2000 Industrial Area
P.O. Box 6

 Migdal Ha'Emeq 2310001, Israel

 (Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F ☒   Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):   __

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):   __

 

---

CONTENTS

Results of Operations and Financial Condition

On February 6, 2017, Enzymotec Ltd. (NASDAQ: ENZY) (the " Company ," " we " or " us ") announced its preliminary financial results for the fourth quarter and full year ended December 31, 2016.  A copy of the press release announcing those preliminary results is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K (this " Form 6-K ") and is incorporated herein by reference.

  

The information in Exhibit 99.1 to this Form 6-K shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

---

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	EYZMOTEC LTD.
Dated: February 6, 2017	By:	/s/ Oren Bryan
		Name: Oren Bryan
		Title:  Chief Financial Officer

 

---

 

EXHIBIT INDEX

 

The following exhibit is furnished as part of this Form 6-K:

 

Exhibit		Description
99.1		Press release dated February 6, 2017 announcing the preliminary results of operations of Enzymotec Ltd. for the fourth quarter and full year ended December 31, 2016

 

---